4.6 Article

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus

Victoria P. Werth et al.

Summary: ALXN1830 treatment in pemphigus showed rapid and significant improvement in disease area index scores, accompanied by reductions in certain blood markers, demonstrating notable efficacy and good tolerability.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Article Dermatology

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

Dedee F. Murrell et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Letter Dermatology

Incidence and Mortality of Pemphigus in France

Lamia Jelti et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)

Review Medicine, General & Internal

Pemphigus

Enno Schmidt et al.

LANCET (2019)

Article Medicine, Research & Experimental

Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

Peter Ulrichts et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Editorial Material Medicine, General & Internal

Rituximab as first-line treatment of pemphigus

Enno Schmidt

LANCET (2017)

Article Medicine, General & Internal

Pemphigus

Michael Kasperkiewicz et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Dermatology

British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017

K. E. Harman et al.

BRITISH JOURNAL OF DERMATOLOGY (2017)

Review Medicine, Research & Experimental

Management of Pemphigus Vulgaris

Mimansa Cholera et al.

ADVANCES IN THERAPY (2016)

Review Hematology

Immunoadsorption in Dermatology

Damian Meyersburg et al.

THERAPEUTIC APHERESIS AND DIALYSIS (2012)

Article Dermatology

High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study

G. Chaidemenos et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)

Article Dermatology

Reliability and Convergent Validity of Two Outcome Instruments for Pemphigus

Misha Rosenbach et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)

Article Dermatology

A randomized double-blind trial of intravenous immunoglobulin for pemphigus

Masayuki Amagai et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)

Article Dermatology

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Dedee E. Murrell et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)

Article Multidisciplinary Sciences

Dependence of antibody-mediated presentation of antigen on FcRn

Shuo-Wang Qiao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Medicine, General & Internal

Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome

John R. Stanley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, Research & Experimental

Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases

N Li et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Biotechnology & Applied Microbiology

Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels

C Vaccaro et al.

NATURE BIOTECHNOLOGY (2005)

Article Dermatology

Expression of FcRn, the MHC class I-related receptor for IgG, in human keratinocytes

K Cauza et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)

Review Biochemistry & Molecular Biology

Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes

VT Nguyen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Dermatology

Protein A immunoadsorption:: a novel and effective adjuvant treatment of severe pemphigus

E Schmidt et al.

BRITISH JOURNAL OF DERMATOLOGY (2003)